...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New bioactive 5-arylcarboximidamidopyrazolo[3,4-c]pyridines: Synthesis, cytotoxic activity, mechanistic investigation and structure-activity relationships
【24h】

New bioactive 5-arylcarboximidamidopyrazolo[3,4-c]pyridines: Synthesis, cytotoxic activity, mechanistic investigation and structure-activity relationships

机译:新的生物活性5-芳基羧酰亚胺胺酰唑唑[3,4-C]吡啶:合成,细胞毒性活性,机械调查和结构 - 活动关系

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, a series of novel substituted pyrazolo[3,4-c]pyridin-5-ylamidines was synthesized and their cytotoxicity against three cancer cell lines (MDA-MB-231, HT-1080, PC-3), as well as a human normal cell line (AG01523) was evaluated. A number of derivatives could strongly reduce cancer cells proliferation and exhibit apoptotic induction capability, while reasonable structure-activity relationships could be extracted. Certain analogues were endowed with low toxicity against normal cells. Cell cycle analysis revealed that most of the active compounds induced a G(0)/G(1) arrest of HT-1080 cells. Moreover, the potential mechanisms of the cytotoxic activity of the promising compounds were investigated in HT-1080 cells, upon study of their effects on the phosphorylation of Akt, ERK and p38 MAPK. Most of the active derivatives inhibit phosphorylation of Akt and ERK and/or induce p38 MAPK phosphorylation, providing a potential indication on the mode of action of this class. (c) 2021 Elsevier Masson SAS. All rights reserved.
机译:本研究合成了一系列新的取代吡唑并[3,4-c]吡啶-5-酰亚胺,并对其对三种癌细胞系(MDA-MB-231、HT-1080、PC-3)和一种人类正常细胞系(AG01523)的细胞毒性进行了评估。许多衍生物可以强烈地减少癌细胞的增殖并表现出诱导凋亡的能力,同时可以提取合理的构效关系。某些类似物对正常细胞具有低毒性。细胞周期分析显示,大多数活性化合物诱导HT-1080细胞G(0)/G(1)阻滞。此外,通过研究这些化合物对Akt、ERK和p38 MAPK磷酸化的影响,我们还研究了它们在HT-1080细胞中的潜在细胞毒性机制。大多数活性衍生物抑制Akt和ERK的磷酸化和/或诱导p38 MAPK磷酸化,为这类药物的作用模式提供了潜在的指示。(c)2021爱思唯尔马松SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号